How mature is Agentic AI for pharmaceutical use?

Agentic AI in pharma is progressing rapidly from pilots to practical impact, reliably accelerating many parts of the puzzle - such as, data harmonization, hypothesis iteration and validation, biomarker identification, clinical trial optimization, etc, with strong guardrails and human oversight. At Owkin, maturity is higher because agents are grounded in high‑quality multimodal data and deep biology context, enabling stronger grounding, clearer reasoning, and more trustworthy recommendations.